Reference

1. Mak K. K., & Pichika M. R. (2019). Artificial intelligence in drug development: present status and future prospects. In Drug Discovery Today (Vol. 24, Issue 3, pp. 773–780). Elsevier Ltd. https://doi.org/10.1016/j.drudis.2018.11.014
2. Smith R. G., & Farquhar A. (2000). The road ahead for knowledge management: an AI perspective. AI magazine, 21(4), 17-17.
3. Gupta R., Srivastava D., Sahu M., Tiwari S., Ambasta R. K., & Kumar P. (2021). Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Molecular Diversity, 25(3), 1315–1360. https://doi.org/10.1007/s11030- 021-10217-3
4. Russell S. J., & Norvig P. (2010). Artificial intelligence a modern approach. London.
5. Ramesh A. N., Kambhampati C., Monson J. R. T., & Drew P. J. (2004). Artificial intelligence in medicine. In Annals of the Royal College of Surgeons of England (Vol. 86, Issue 5, pp. 334–338). https://doi.org/10.1308/147870804290
6. Paul D., Sanap G., Shenoy S., Kalyane D., Kalia K., & Tekade R. K. (2021). Artificial intelligence in drug discovery and development. In Drug Discovery Today (Vol. 26, Issue 1, pp. 80–93). Elsevier Ltd. https://doi.org/10.1016/j.drudis.2020.10.010
7. Lamberti M. J., Wilkinson M., Donzanti B. A., Wohlhieter G. E., Parikh S., Wilkins R. G., & Getz K. (2019). A Study on the Application and Use of Artificial Intelligence to Support Drug Development. Clinical Therapeutics, 41(8), 1414–1426. https://doi.org/10.1016/j.clinthera.2019.05.018
8. Vora L. K., Gholap A. D., Jetha K., Thakur R. R. S., Solanki H. K., & Chavda V. P. (2023). Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. In Pharmaceutics (Vol. 15, Issue 7). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/pharmaceutics15071916
9. Pan X., Lin X., Cao D., Zeng X., Yu P. S., He L., Nussinov R., & Cheng F. (n.d.). Deep learning for drug repurposing: methods, databases, and applications.
10. Moshayedi A. J., Roy A. S., Kolahdooz A., & Shuxin Y. (2022). Deep Learning Application  Pros and      Cons    Over    Algorithm. https://doi.org/10.4108/10.4108/airo.v1i.19
11. Agrawal P. (2018). Artificial Intelligence in Drug Discovery and Development. Journal of Pharmacovigilance, 06(02). https://doi.org/10.4172/2329-6887.1000e173
12. Chopra H., Baig A. A., Gautam R. K., & Kamal M. A. (2022). Application of Artificial Intelligence in Drug Discovery. Current Pharmaceutical Design, 28(33), 2690–2703. https://doi.org/10.2174/1381612828666220608141049
13. Das S., Dey R., & Nayak A. K. (2021). Artificial intelligence in pharmacy. In Indian Journal of Pharmaceutical Education and Research (Vol. 55, Issue 2, pp. 304–318). Association of Pharmaceutical Teachers of India. https://doi.org/10.5530/ijper.55.2.68
14. Hagendorff T., & Wezel K. (2020). 15 challenges for AI: or what AI (currently) can’t do. AI and Society, 35(2), 355–365. https://doi.org/10.1007/s00146-019-00886-y
15. Terranova N., Venkatakrishnan K., & Benincosa L. J. (2021). Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities. In AAPS Journal (Vol. 23, Issue 4). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1208/s12248-021-00593-x
16. Askin S., Burkhalter D., Calado G., & El Dakrouni S. (2023). Artificial Intelligence Applied to clinical trials: opportunities and challenges. Health and Technology, 13(2), 203-213.
17. Sarkar C., Das B., Rawat V. S., Wahlang J. B., Nongpiur A., Tiewsoh I., Lyngdoh N. M., Das D., Bidarolli M., & Sony H. T. (2023). Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development. In International Journal of Molecular Sciences (Vol. 24, Issue 3). MDPI. https://doi.org/10.3390/ijms24032026
18. Chen Z., Liu X., Hogan W., Shenkman E., & Bian J. (2020). Applications of artificial intelligence in drug development using real-world data. Drug Discovery Today, 00. https://doi.org/10.1016/j
19. Blanco-González A., Cabezón A., Seco-González A., Conde-Torres D., Antelo-Riveiro P., Piñeiro Á., & Garcia-Fandino R. (2023). The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies. In Pharmaceuticals (Vol. 16, Issue 6). Multidisciplinary          Digital Publishing Institute (MDPI). https://doi.org/10.3390/ph16060891
20. Jia, W., Sun, M., Lian, J., & Hou, S. (2022). Feature dimensionality reduction: a review. Complex and Intelligent Systems, 8(3), 2663–2693. https://doi.org/10.1007/s40747- 021-00637-x
21. Chen W., Liu X., Zhang S., & Chen S. (2023). Artificial intelligence for drug discovery: Resources, methods, and applications. In Molecular Therapy - Nucleic Acids (Vol. 31, pp. 691–702). Cell Press. https://doi.org/10.1016/j.omtn.2023.02.019
22. Jiménez-Luna J., Grisoni F., Weskamp N., & Schneider G. (2021). Artificial intelligence in drug discovery: recent advances and future perspectives. Expert Opinion on Drug Discovery, 16(9), 949–959. https://doi.org/10.1080/17460441.2021.1909567
23. Schauperl M., & Denny R. A. (2022). AI-based protein structure prediction in drug discovery: impacts and challenges. Journal of   Chemical   Information   and Modeling, 62(13), 3142-3156. https://doi.org/10.1021/acs.jcim.2c00026
24. Zheng S., Li Y., Chen S., Xu J., & Yang Y. (n.d.). Predicting Drug Protein Interaction using Quasi-Visual Question Answering System. https://doi.org/10.1101/588178
25. Selvaraj C., Chandra I., & Singh S. K. (2022). Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries. In Molecular Diversity (Vol. 26, Issue 3, pp. 1893–1913). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s11030-021-10326-z
26. Lodhi D. S., Verma M., Golani P., Pawar A. S., & Nagdev S. (2022). Impact of Artificial Intelligence in the Pharmaceutical Industry on Working Culture: A Review. In International Journal of Pharmaceutical Sciences and Nanotechnology (Vol. 15, Issue 1, pp. 5771–5780).           Pharma Book  Syndicate. https://doi.org/10.37285/ijpsn.2022.15.1.5
27. Zhong X., & D’Antona A. M. (2021). Recent advances in the molecular design and applications of multispecific biotherapeutics. In Antibodies (Vol. 10, Issue 2). MDPI AG. https://doi.org/10.3390/antib10020013
28. Chen S., & Jung Y. (2021). Deep Retrosynthetic Reaction Prediction using Local Reactivity and Global Attention. JACS Au, 1(10), 1612–1620. https://doi.org/10.1021/jacsau.1c00246
29. Johansson S., Thakkar A., Kogej T., Bjerrum E., Genheden S., Bastys T., ... & Engkvist, O. (2019). AI-assisted synthesis prediction. Drug Discovery Today: Technologies, 32, 65-72. https://doi.org/10.1016/j.ddtec.2020.06.002
30. Lee J. W., Maria-Solano M. A., Vu T. N. L., Yoon S., & Choi S. (2022). Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD). In Biochemical Society Transactions (Vol. 50, Issue 1, pp. 241–252). Portland Press Ltd. https://doi.org/10.1042/BST20211240
31. Kulkarni V. S., Alagarsamy V., Solomon V. R., Jose P. A., & Murugesan S. (2023). Drug Repurposing: An Effective Tool in Modern Drug Discovery. Russian Journal of Bioorganic Chemistry, 49(2), 157–166. https://doi.org/10.1134/S1068162023020139
32. Kumar S., & Roy V. (2023). Repurposing Drugs: An Empowering Approach to Drug Discovery and Development. In Drug Research. Georg Thieme Verlag. https://doi.org/10.1055/a-2095-0826
33. Bhattamisra S. K., Banerjee P., Gupta P., Mayuren J., Patra S., & Candasamy M. (2023). Artificial Intelligence in Pharmaceutical and Healthcare Research. In Big Data and Cognitive Computing (Vol. 7, Issue 1). MDPI. https://doi.org/10.3390/bdcc7010010
34. Feng J., Phillips R. v., Malenica I., Bishara A., Hubbard A. E., Celi L. A., & Pirracchio R. (2022). Clinical artificial intelligence quality improvement: towards continual monitoring and updating of AI algorithms in healthcare. Npj Digital Medicine, 5(1). https://doi.org/10.1038/s41746-022-00611-y
35. Kumar, P., Irfan, M., Chauhan, B., Mittal, S., & Chaturvedi, S. (2022). Significance of Clinical Trials in Drug Discovery. In J Res Med Dent Sci (Vol. 10, Issue S1). www.jrmds.in